New Findings Reveal Untreated Sleep Apnea Nearly Doubles Parkinson’s Risk, But CPAP Therapy Offers Protection

New research published in JAMA Neurology indicates that individuals suffering from obstructive sleep apnea who fail to seek or maintain treatment face a substantially higher likelihood of developing Parkinson’s disease later in life. The comprehensive epidemiological study, which examined electronic health records spanning more than two decades, suggests that using continuous positive airway pressure, commonly known as CPAP, can effectively mitigate this neurological risk by ensuring steady nighttime airflow and preserving optimal sleep quality.

The findings mark a significant step forward in understanding the complex intersection between sleep architecture and neurodegenerative disorders. As the global medical community continues to seek modifiable risk factors for conditions like Parkinson’s disease, this large-scale analysis provides compelling evidence that routine management of common sleep disorders may serve as a crucial shield for long-term brain health.

Methodology and Scope of the Landmark Study

The study, released on November 24, represents one of the most exhaustive evaluations of its kind. Researchers systematically analyzed the electronic health records of more than 11 million U.S. military veterans who received comprehensive medical care through the Department of Veterans Affairs between 1999 and 2022. This vast repository of longitudinal health data allowed investigators to track medical diagnoses, treatment compliance, and disease onset across a diverse and aging demographic over a 23-year timeframe.

The project was spearheaded by a multidisciplinary team of researchers from Oregon Health & Science University (OHSU) and the Portland VA Health Care System. By leveraging the extensive database provided by the VA, the research team was able to control for numerous confounding variables that typically complicate neurological studies, offering unprecedented statistical power to their final conclusions.

Understanding Parkinson’s Disease and the Aging Population

Parkinson’s disease is a progressive, neurodegenerative disorder that predominantly affects movement, motor control, and balance. Characterized by the gradual loss of dopamine-producing neurons in the brain, the condition currently impacts an estimated 1 million people across the United States. Epidemiological data demonstrates that the baseline probability of developing Parkinson’s increases progressively each year following the age of 60.

Historically, medical science has focused heavily on genetic predispositions, environmental toxin exposures, and age-related cellular decline as the primary drivers of the disease. However, this new body of research highlights long-term, untreated sleep apnea as a critical, yet modifiable, contributing factor that can accelerate or exacerbate neurodegenerative processes.

Controlling for Confounding Variables: The Statistical Reality

To ensure the accuracy of their findings, the investigative team meticulously adjusted for a wide array of key health contributors known to influence both sleep apnea and neurological health. These variables included patient age, body mass index, obesity rates, tobacco use, and high blood pressure.

Even after isolating and accounting for these major health risk factors, the statistical correlation between untreated sleep apnea and the subsequent onset of Parkinson’s disease remained striking. Among the millions of veterans evaluated in the study who suffered from sleep apnea, individuals who did not utilize CPAP therapy were found to be nearly twice as likely to receive a clinical diagnosis of Parkinson’s disease compared to those who consistently used the treatment.

Co-author Dr. Gregory Scott, an assistant professor of pathology in the OHSU School of Medicine and a staff pathologist at the Portland VA, contextualized the findings for patients. "It’s not at all a guarantee that you’re going to get Parkinson’s, but it significantly increases the chances," Dr. Scott explained, emphasizing the probabilistic nature of the risk without minimizing its clinical significance.

Cellular Mechanisms: How Sleep Apnea Harms the Brain

To understand why a respiratory disorder during sleep could impact long-term neurological health, researchers examined the physiological mechanics of obstructive sleep apnea. The condition is characterized by repeated episodes where upper airway muscles collapse during sleep, causing breathing to repeatedly stop and restart. These interruptions frequently starve the body and brain of sufficient oxygen, leading to intermittent hypoxia and frequent micro-arousals throughout the night.

Dr. Lee Neilson, lead author of the study, assistant professor of neurology at OHSU, and a staff neurologist at the Portland VA, elaborated on the cellular consequences of these nocturnal events. "If you stop breathing and oxygen is not at a normal level, your neurons are probably not functioning at a normal level either," Dr. Neilson stated.

Over prolonged periods, the cumulative physiological toll of nocturnal oxygen deprivation becomes substantial. "Add that up night after night, year after year, and it may explain why fixing the problem by using CPAP may build in some resilience against neurodegenerative conditions, including Parkinson’s," Neilson added. This chronic cellular stress can trigger neuroinflammation, oxidative stress, and protein misfolding—processes intimately tied to the death of dopaminergic neurons.

Shifting Clinical Perspectives and Practice Management

The implications of the OHSU and Portland VA study extend far beyond statistical correlations; they hold the potential to fundamentally transform clinical practices across neurology and sleep medicine. For clinicians treating aging populations, evaluating and aggressively treating sleep disorders may no longer be viewed merely as a matter of improving daytime alertness or cardiovascular health, but as a proactive neuroprotective strategy.

Dr. Neilson noted that the revelations from the study have already shifted his own approach to patient care. When asked about the broader application of the research in a clinical setting, he confirmed that the findings reinforce the absolute necessity of prioritizing sleep health for all patients, particularly those exhibiting early markers of neurological vulnerability. "I think it will change my practice," he affirmed.

Overcoming Patient Hesitancy Toward CPAP Compliance

Despite the proven efficacy of continuous positive airway pressure therapy in maintaining steady airflow and improving oxygen saturation, many patients diagnosed with obstructive sleep apnea display initial hesitation or resistance toward adopting the treatment. Modern CPAP machines require an adjustment period, and concerns regarding mask comfort, noise, and lifestyle disruptions often deter consistent use.

However, clinical observations from the VA health system suggest that the reality of CPAP therapy is frequently much more positive than anticipated. Dr. Scott highlighted the feedback gathered from veterans who have successfully integrated the devices into their nightly routines.

"The veterans who use their CPAP love it," Dr. Scott observed. "They’re telling other people about it. They feel better, they’re less tired." Dr. Scott expressed optimism that the newly established link between untreated sleep apnea and Parkinson’s disease might serve as a powerful motivator. "Perhaps if others know about this reduction in risk of Parkinson’s disease, it will further convince people with sleep apnea to give CPAP a try."

Collaborative Research Team and Institutional Support

The breadth and depth of the JAMA Neurology study were made possible through a collaborative effort involving prominent academic institutions and healthcare networks. Alongside lead researchers Dr. Lee Neilson and Dr. Gregory Scott, the study’s co-author roster included Isabella Montano, B.A., Dr. Jasmin May, Dr. Jonathan Elliott, and Dr. Miranda Lim, all representing OHSU and the Portland VA Health Care System. Additional vital contributions came from Dr. Yeilim Cho and Dr. Jeffrey Iliff of the University of Washington and the VA Puget Sound Health Care System.

Funding and logistical support for the intricate multi-year project were drawn from a diverse portfolio of federal agencies, non-profit foundations, and research grants. The Department of Veterans Affairs provided core backing through multiple specific grant awards, including BX005760, CX00253, I01RX004822, I01RX005371, CX002022, BX006155, and Bx006155.

Additional financial contributions were furnished by the John and Tami Marick Family Foundation, the Collins Medical Trust, and the National Institute on Aging of the National Institutes of Health under award P30AG066518. Furthermore, the U.S. Army Medical Research Acquisition Activity—headquartered at Fort Detrick, Maryland—provided support under award numbers HT9425-24-1-0774 and HT9425-24-1-0775.

In accordance with standard scientific transparency, the study authors formally noted that all opinions, interpretations, data analyses, conclusions, and clinical recommendations expressed in the research are strictly their own. These viewpoints do not necessarily represent the official endorsements or policies of the Department of Defense, the National Institutes of Health, the Department of Veterans Affairs, or any other funding organization.

Broader Public Health Implications and Future Directions

As the medical community digests the implications of this extensive research, public health officials are expected to place a renewed emphasis on sleep screening protocols. Obstructive sleep apnea remains an underdiagnosed condition affecting millions of individuals worldwide who attribute their chronic fatigue, cognitive fog, and snoring to normal aging or lifestyle factors.

By establishing a direct numerical link between untreated respiratory disruptions during sleep and the increased incidence of neurodegenerative illness, this study provides a compelling rationale for early diagnostic interventions. Future research endeavors building upon the OHSU and Portland VA findings will likely investigate whether early initiation of CPAP therapy can completely reverse cellular damage or if its primary value lies strictly in risk reduction and disease prevention.

For now, healthcare providers strongly encourage anyone experiencing chronic snoring, witnessed apneas during sleep, or unrefreshing rest to seek professional medical evaluation. Addressing sleep apnea promptly not only restores immediate quality of life through enhanced energy and cardiovascular protection, but it may also safeguard the brain against the devastating progressive toll of neurodegenerative diseases like Parkinson’s in the decades to come.